M. Mazier
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Colorectal Cancer Surgical Treatments
Papers in
- Oncology 10
- Colorectal Cancer Treatments and Studies 8
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 1
-
- Gastric Cancer Management and Outcomes 4
- Co-authors
- Scott Berry (7 shared papers)Fernando Rivera (7 shared papers)David Cunningham (8 shared papers)Albrecht Kretzschmar (5 shared papers)M. Michael (5 shared papers)Eric Van Cutsem (6 shared papers)John Bridgewater (3 shared papers)Marc Peeters (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Blood (1 paper)Annals of Oncology (1 paper)Haematologica (1 paper)European Journal of Cancer Supplements (2 papers)
- Partner nations
- AustraliaSpainUnited Kingdom
In The Last Decade
M. Mazier
10 papers receiving 538 citations
Peers
Comparison fields: 5 of 43
- Hepatology 131
- Oncology 416
- Pulmonary and Respiratory Medicine 115
- Hematology 29
- Pathology and Forensic Medicine 36
Countries citing papers authored by M. Mazier
This map shows the geographic impact of M. Mazier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mazier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mazier more than expected).
Fields of papers citing papers by M. Mazier
This network shows the impact of papers produced by M. Mazier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mazier. The network helps show where M. Mazier may publish in the future.
Co-authors
The 22 scholars most cited alongside M. Mazier, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 425 | |
| 2 | 2006 | 40 | |
| 3 | 2013 | 27 | |
| 4 | 2008 | 19 | |
| 5 | 2007 | 14 | |
| 6 | 2006 | 10 | |
| 7 | 2009 | 6 | |
| 8 | 2007 | 6 | |
| 9 | SAFETY AND EFFICACY OF BEVACIZUMAB (BEV) AND CHEMOTHERAPY IN ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): RESULTS FROM THE BEAT OBSERVATIONAL COHORT STUDY | 2009 | 5 |
| 10 | 2011 | 1 |
About M. Mazier
M. Mazier is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Hematology and Molecular Biology, having authored 10 papers that have together received 553 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (5 papers), Gastric Cancer Management and Outcomes (4 papers), Cancer Genomics and Diagnostics (3 papers), Multiple Myeloma Research and Treatments (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Protein Degradation and Inhibitors (1 paper) and Cholinesterase and Neurodegenerative Diseases (1 paper). The work is most often cited by research in Hepatology (131 citations), Oncology (416 citations), Pulmonary and Respiratory Medicine (115 citations), Hematology (29 citations) and Pathology and Forensic Medicine (36 citations). M. Mazier has collaborated with scholars based in Australia, Spain and United Kingdom. Frequent co-authors include Scott Berry, Fernando Rivera, David Cunningham, Albrecht Kretzschmar, M. Michael, Eric Van Cutsem, John Bridgewater, Marc Peeters, Vassilis Georgoulias and J.-L. Canon. Their work appears in journals such as Journal of Clinical Oncology, Blood, Annals of Oncology, Haematologica and European Journal of Cancer Supplements.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.